RecruitingNot ApplicableNCT07220798

Improving Self-Care of Caregivers of Adults in Homecare With Heart Failure and Cognitive Impairment

Improving Self-Care of Caregivers of Adults in Homecare With Heart Failure and Cognitive Impairment (iCare4Me Homecare)


Sponsor

Visiting Nurse Service of New York

Enrollment

316 participants

Start Date

May 28, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

This RCT design will enroll 256 informal caregivers (spouse/partner or child) of HHC patients with HF/CI and 60 patients with HF and mild to moderate CI (60 dyads). After collecting baseline data, we will block randomize the caregivers 1:1 to the ViCCY intervention or comparator group, stratifying randomization by caregiver sex (male/female), relationship (spouse/partner or child), and race (white/other)- factors known to influence caregiving burden, perceived stress, and receptivity to the intervention. We will encourage caregivers to use their own devices but provide tablet devices with wireless network access if needed. The intervention group will receive 10 sessions of ViCCY over 6 months.


Eligibility

Min Age: 18 YearsMax Age: 101 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a behavioral approach called ViCCY for people with caregiver burden, cognitive impairment, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 101 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALViCCY

The intervention group will receive 10 Health Coach sessions of ViCCY over 6-months.


Locations(1)

VNS Health

New York, New York, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07220798


Related Trials